全球植物抗体市场

预计到 2030 年全球植物抗体市场规模将达到 7,950 万美元

全球植物抗体市场规模预计在2024年为5,320万美元，到2030年将达到7,950万美元，2024年至2030年的复合年增长率为6.9%。烟草是本报告分析的细分市场之一，预计其复合年增长率为8.8%，到分析期结束时规模将达到2,430万美元。豆类细分市场在分析期间内的复合年增长率预计为4.6%。

美国市场规模估计为 1,450 万美元，而中国市场预计复合年增长率为 11.2%

预计到2024年，美国植物抗体市场规模将达到1,450万美元。作为世界第二大经济体，中国市场规模预计将在2030年达到1,690万美元，2024年至2030年的复合年增长率为11.2%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间的复合年增长率分别为3.3%和6.8%。在欧洲，预计德国的复合年增长率为4.6%。

全球植物抗体市场－主要趋势与驱动因素摘要

什么是植物抗体？为什么生物製药公司对它们感兴趣？

植物抗体是利用分子农业技术在基因工程植物中产生的抗体。它们具有与哺乳动物单株抗体相似的功能，但利用烟草、玉米、水稻和大麦等植物表现系统合成。这些植物来源抗体为传统生物製药生产提供了一条替代途径，特别适用于疫苗、治疗和诊断领域。

这个概念具有许多优势，包括降低生产成本、降低人类病原体污染风险以及可扩展的农业生产。植物抗体正被研究作为感染疾病、癌症和自体免疫疾病治疗和诊断套件的组成部分。随着对快速灵活生产平台的需求不断增长，尤其是在全球卫生紧急情况下，植物抗体的重要性日益凸显。

支持植物抗体生产的技术是如何发展？

植物抗体的生产涉及使用农桿菌介导的转化或病毒载体等技术将抗体编码基因插入植物细胞。这些基因改造植物随后在其叶子和种子中产生目标抗体。收穫的材料经过加工和纯化，以提取功能性抗体。植物表现载体、糖基化控制和下游纯化技术的进步提高了产量及其与人类抗体的生物等效性。

利用植物病毒载体的瞬时表现系统的最新创新，实现了快速生产週期，并使其能够适应新的疾病目标。植物细胞培养、密闭式培养和分子设计的改进，进一步实现了批次间性能的一致性。糖工程技术正被用于植物来源抗体的人源化，以提高疗效并降低免疫抗原性。

该应用程式在哪里发展以及谁在使用 Plantibody？

一些研究和早期临床研究正在评估植物抗体对伊波拉出血热、兹卡、新冠肺炎和某些癌症等疾病的疗效。一些生物技术公司和公共卫生机构已经启动了使用本氏烟和其他模式植物的试验和中试生产计画。植物抗体也在兽医学、食品安全诊断和环境生物感测领域研究。

製药公司越来越多地考虑采用基于植物的系统进行大规模、成本敏感的抗体生产。人们对生物相似药和新型疗法的日益关注，推动了对灵活、可扩展且生物安全的生产方式的需求。诊断套件开发商正在利用植物抗体开发快速、稳定且易于运输的检测解决方案，尤其是在资源匮乏的环境中。

植物抗体市场的成长受到多种因素的推动。

植物抗体市场的成长动力源自于对经济高效的生物疗法药物日益增长的需求、植物表现系统基因工程的改进，以及对新兴疾病快速抗体生产日益增长的需求。瞬时表达技术的扩展、下游製程的改进以及植物生物安全性的提升，正在推动其应用。

全球卫生诊断领域的应用、对分子农业作为疫情应对措施的兴趣，以及生技公司与农业研究人员之间的合作，正在加速其发展。在即时检测、兽医治疗和被动免疫策略中的应用也增加了市场潜力。随着法律规范不断发展以支持植物来源生技药品，植物抗体有望在製药研发线和全球卫生策略中得到更广泛的应用。

部分

基因改造作物（烟草、豆类、谷类、种子/块茎、水果/蔬菜、其他基因改造作物）、技术（传统技术、组织培养技术、育种/杂交技术、基因改造种子技术、其他技术）、用途（自体免疫疾病用途、癌症用途、感染疾病用途、疫苗接种用途、牙科用途、其他用途）、最终生物/製药公司、学术用途（生物/製药公司、学术用途）

受访公司范例

• Agrisera AB
• Biolex Therapeutics（Synthon）
• Fraunhofer IME
• Greenovation Biotech GmbH
• IBIO, Inc.
• Icon Genetics（Nomad Bioscience）
• Kentucky BioProcessing Inc.
• Leaf Expression Systems
• Mapp Biopharmaceutical, Inc.
• Medicago Inc.
• Morphosys AG
• Planet Biotechnology Inc.
• PlantForm Corporation
• PlantiBodies（startup）
• Protalix BioTherapeutics Inc.
• Qualcomm of plantibodies **Ventria Bioscience Inc.
• Pfizer Inc.
• ZEA Biosciences
• Biocon Limited
• iVitria/Ventria Affiliates**

人工智慧集成

全球产业分析师利用可操作的专家内容和人工智慧工具改变市场和竞争情报。

Global Industry Analysts 没有遵循典型的 LLM 或特定于行业的 SLM查询，而是建立了一个从世界各地的专家收集的内容库，其中包括视频录像、博客、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地和进出口（成品和原始设备製造商）情况预测其竞争地位的变化。这种复杂而多面的市场动态预计将以多种方式影响竞争对手，包括销货成本(COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

• 市场概览
• 主要企业
• 市场趋势和驱动因素
• 全球市场展望

第三章市场分析

• 美国
• 加拿大
• 日本
• 中国
• 欧洲
• 法国
• 德国
• 义大利
• 英国
• 西班牙
• 俄罗斯
• 其他欧洲国家
• 亚太地区
• 澳洲
• 印度
• 韩国
• 其他亚太地区
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中东
• 伊朗
• 以色列
• 沙乌地阿拉伯
• 阿拉伯聯合大公国
• 其他中东地区
• 非洲

第四章 比赛

Global Plantibodies Market to Reach US$79.5 Million by 2030

The global market for Plantibodies estimated at US$53.2 Million in the year 2024, is expected to reach US$79.5 Million by 2030, growing at a CAGR of 6.9% over the analysis period 2024-2030. Tobacco, one of the segments analyzed in the report, is expected to record a 8.8% CAGR and reach US$24.3 Million by the end of the analysis period. Growth in the Legumes segment is estimated at 4.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$14.5 Million While China is Forecast to Grow at 11.2% CAGR

The Plantibodies market in the U.S. is estimated at US$14.5 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$16.9 Million by the year 2030 trailing a CAGR of 11.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.3% and 6.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.6% CAGR.

Global Plantibodies Market - Key Trends & Drivers Summarized

What Are Plantibodies and Why Are They Attracting Biopharmaceutical Interest?

Plantibodies are antibodies produced in genetically engineered plants through molecular farming. They function similarly to mammalian-derived monoclonal antibodies but are synthesized using plant expression systems such as tobacco, corn, rice, or barley. These plant-based antibodies offer an alternative route to traditional biopharmaceutical manufacturing, particularly for vaccines, therapeutics, and diagnostic agents.

The concept offers several advantages including lower production costs, reduced risk of contamination with human pathogens, and scalable agriculture-based manufacturing. Plantibodies are being explored for the treatment of infectious diseases, cancer, autoimmune conditions, and as components in diagnostic kits. Their relevance grew with increasing demand for rapid and flexible production platforms, especially during global health emergencies.

How Is the Technology Behind Plantibody Production Evolving?

Plantibody production involves inserting antibody-encoding genes into plant cells using techniques like Agrobacterium-mediated transformation or viral vectors. These transgenic plants then produce the desired antibodies in their leaves or seeds. The harvested material is processed and purified to extract functional antibodies. Advances in plant expression vectors, glycosylation control, and downstream purification have improved yield and biological equivalence to human antibodies.

Recent innovations in transient expression systems using plant viral vectors allow rapid production cycles and adaptability to emerging disease targets. Improvements in plant cell culture, containment farming, and molecular design have further enabled consistent performance across batches. Glycoengineering techniques are being used to humanize plant-derived antibodies for improved efficacy and reduced immunogenicity.

Where Are Applications Expanding and Who Is Using Plantibodies?

Research and early-stage clinical studies are evaluating plantibodies for conditions such as Ebola, Zika, COVID-19, and certain cancers. Several biotechnology companies and public health institutions have initiated trials and pilot production programs using Nicotiana benthamiana and other model plants. Plantibodies are also being explored in veterinary medicine, food safety diagnostics, and environmental biosensing.

Pharmaceutical producers are increasingly considering plant-based systems for large-scale, cost-sensitive antibody production. As biosimilars and novel therapeutics become more prominent, the demand for flexible, scalable, and biosafe manufacturing alternatives is growing. Diagnostic kit developers are using plantibodies to create rapid, stable, and transportable testing solutions, particularly for use in low-resource settings.

Growth in the Plantibodies market is driven by several factors…

Growth in the plantibodies market is driven by increasing need for cost-effective biotherapeutics, improved genetic engineering of plant expression systems, and growing demand for rapid antibody production in response to emerging diseases. Expansion of transient expression techniques, improved downstream processing, and the rise of plant-based biosafety profiles are supporting adoption.

Application in global health diagnostics, interest in molecular farming for pandemic preparedness, and partnerships between biotech firms and agriculture researchers are accelerating development. Use in point-of-care testing, veterinary therapeutics, and passive immunization strategies also contributes to market potential. As regulatory frameworks evolve to support plant-based biologics, plantibodies are positioned to gain greater acceptance in pharmaceutical pipelines and global health strategies.

SCOPE OF STUDY:

The report analyzes the Plantibodies market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Transgenic Crop (Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables, Other Transgenic Crops); Technique (Conventional Method Technique, Tissue Culture Technique, Breeding & Sexual Crossing Technique, Transgenic Seeds Technique, Other Techniques); Application (Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application, Other Applications); End-Use (Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 33 Featured) -

• Agrisera AB
• Biolex Therapeutics (Synthon)
• Fraunhofer IME
• Greenovation Biotech GmbH
• IBIO, Inc.
• Icon Genetics (Nomad Bioscience)
• Kentucky BioProcessing Inc.
• Leaf Expression Systems
• Mapp Biopharmaceutical, Inc.
• Medicago Inc.
• Morphosys AG
• Planet Biotechnology Inc.
• PlantForm Corporation
• PlantiBodies (startup)
• Protalix BioTherapeutics Inc.
• Qualcomm of plantibodies?** Ventria Bioscience Inc.
• Pfizer Inc.
• ZEA Biosciences
• Biocon Limited
• iVitria / Ventria Affiliates**

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Plantibodies - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Demand for Cost-Effective Biologics Propels Interest in Plantibody Production Platforms
  • Advancements in Plant Molecular Farming Strengthen the Business Case for Plant-Derived Therapeutic Antibodies
  • Increasing Global Emphasis on Pandemic Preparedness Throws the Spotlight on Rapid-Scale Antibody Manufacturing via Plants
  • Lower Risk of Human Pathogen Contamination Supports Regulatory Momentum for Plant-Based Biopharmaceuticals
  • Growth in Monoclonal Antibody Therapies Expands the Addressable Market for Alternative Expression Systems
  • Technological Innovations in Transient Expression Systems Drive Rapid and Scalable Plantibody Yields
  • Shift Toward Decentralized and Low-Cost Biomanufacturing Fuels Adoption in Emerging and Low-Resource Regions
  • Use of Plantibodies in Veterinary and Agricultural Applications Opens Non-Human Health Market Opportunities
  • Global Expansion of Biosimilar and Biobetter Markets Creates Long-Term Demand for Low-Cost Antibody Production Systems
  • Inclusion of Plantibodies in Orphan Drug and Rare Disease Pipelines Enhances Market Differentiation
  • Challenges in Downstream Processing and Product Consistency Throw the Spotlight on Bioprocess Optimization
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Plantibodies Market Analysis of Annual Sales in US$ for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Plantibodies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Plantibodies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for Plantibodies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Tobacco by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Tobacco by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for Tobacco by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Legumes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Legumes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for Legumes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Cereals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Cereals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for Cereals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Seeds & Tubers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Seeds & Tubers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for Seeds & Tubers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Fruits & Vegetables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Fruits & Vegetables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Fruits & Vegetables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Other Transgenic Crops by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Other Transgenic Crops by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 22: World 16-Year Perspective for Other Transgenic Crops by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Transgenic Seeds Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Transgenic Seeds Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 25: World 16-Year Perspective for Transgenic Seeds Technique by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Other Techniques by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Other Techniques by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 28: World 16-Year Perspective for Other Techniques by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Conventional Method Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Conventional Method Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 31: World 16-Year Perspective for Conventional Method Technique by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Tissue Culture Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Tissue Culture Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 34: World 16-Year Perspective for Tissue Culture Technique by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Breeding & Sexual Crossing Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Breeding & Sexual Crossing Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 37: World 16-Year Perspective for Breeding & Sexual Crossing Technique by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Autoimmune Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Autoimmune Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 40: World 16-Year Perspective for Autoimmune Diseases Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 43: World 16-Year Perspective for Cancer Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 44: World Recent Past, Current & Future Analysis for Infectious Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 45: World Historic Review for Infectious Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 46: World 16-Year Perspective for Infectious Diseases Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 47: World Recent Past, Current & Future Analysis for Immunization Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 48: World Historic Review for Immunization Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 49: World 16-Year Perspective for Immunization Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 50: World Recent Past, Current & Future Analysis for Dentistry Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 51: World Historic Review for Dentistry Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 52: World 16-Year Perspective for Dentistry Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 53: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 54: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 55: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 56: World Recent Past, Current & Future Analysis for Biotech & Pharma Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 57: World Historic Review for Biotech & Pharma Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 58: World 16-Year Perspective for Biotech & Pharma Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 59: World Recent Past, Current & Future Analysis for Academic & Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 60: World Historic Review for Academic & Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 61: World 16-Year Perspective for Academic & Research Institutes End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 62: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 63: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 64: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Plantibodies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 65: USA Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 66: USA Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 67: USA 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
  • TABLE 68: USA Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 69: USA Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 70: USA 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
  • TABLE 71: USA Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 72: USA Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 73: USA 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 74: USA Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 75: USA Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 76: USA 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• CANADA
  • TABLE 77: Canada Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Canada Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 79: Canada 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
  • TABLE 80: Canada Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Canada Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 82: Canada 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
  • TABLE 83: Canada Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Canada Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 85: Canada 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 86: Canada Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Canada Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 88: Canada 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• JAPAN
  • Plantibodies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 89: Japan Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Japan Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 91: Japan 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
  • TABLE 92: Japan Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Japan Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 94: Japan 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
  • TABLE 95: Japan Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Japan Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 97: Japan 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 98: Japan Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Japan Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 100: Japan 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• CHINA
  • Plantibodies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 101: China Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 102: China Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 103: China 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
  • TABLE 104: China Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 105: China Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 106: China 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
  • TABLE 107: China Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 108: China Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 109: China 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 110: China Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 111: China Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 112: China 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• EUROPE
  • Plantibodies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 113: Europe Recent Past, Current & Future Analysis for Plantibodies by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 114: Europe Historic Review for Plantibodies by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 115: Europe 16-Year Perspective for Plantibodies by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
  • TABLE 116: Europe Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Europe Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 118: Europe 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
  • TABLE 119: Europe Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Europe Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 121: Europe 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
  • TABLE 122: Europe Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Europe Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 124: Europe 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 125: Europe Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Europe Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 127: Europe 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• FRANCE
  • Plantibodies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 128: France Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 129: France Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 130: France 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
  • TABLE 131: France Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 132: France Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 133: France 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
  • TABLE 134: France Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 135: France Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 136: France 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 137: France Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 138: France Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 139: France 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• GERMANY
  • Plantibodies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 140: Germany Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Germany Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 142: Germany 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
  • TABLE 143: Germany Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Germany Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 145: Germany 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
  • TABLE 146: Germany Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Germany Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 148: Germany 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 149: Germany Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Germany Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 151: Germany 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• ITALY
  • TABLE 152: Italy Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Italy Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 154: Italy 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
  • TABLE 155: Italy Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Italy Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 157: Italy 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
  • TABLE 158: Italy Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Italy Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 160: Italy 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 161: Italy Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Italy Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 163: Italy 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• UNITED KINGDOM
  • Plantibodies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 164: UK Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 165: UK Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 166: UK 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
  • TABLE 167: UK Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 168: UK Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 169: UK 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
  • TABLE 170: UK Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 171: UK Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 172: UK 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 173: UK Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 174: UK Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 175: UK 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• SPAIN
  • TABLE 176: Spain Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Spain Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 178: Spain 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
  • TABLE 179: Spain Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Spain Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 181: Spain 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
  • TABLE 182: Spain Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Spain Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 184: Spain 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 185: Spain Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Spain Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 187: Spain 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• RUSSIA
  • TABLE 188: Russia Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Russia Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 190: Russia 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
  • TABLE 191: Russia Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Russia Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 193: Russia 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
  • TABLE 194: Russia Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Russia Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 196: Russia 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 197: Russia Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Russia Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 199: Russia 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• REST OF EUROPE
  • TABLE 200: Rest of Europe Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Rest of Europe Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 202: Rest of Europe 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
  • TABLE 203: Rest of Europe Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Rest of Europe Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 205: Rest of Europe 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
  • TABLE 206: Rest of Europe Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Rest of Europe Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 208: Rest of Europe 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 209: Rest of Europe Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Rest of Europe Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 211: Rest of Europe 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• ASIA-PACIFIC
  • Plantibodies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 212: Asia-Pacific Recent Past, Current & Future Analysis for Plantibodies by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 213: Asia-Pacific Historic Review for Plantibodies by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 214: Asia-Pacific 16-Year Perspective for Plantibodies by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
  • TABLE 215: Asia-Pacific Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Asia-Pacific Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 217: Asia-Pacific 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
  • TABLE 218: Asia-Pacific Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Asia-Pacific Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 220: Asia-Pacific 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
  • TABLE 221: Asia-Pacific Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Asia-Pacific Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 223: Asia-Pacific 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 224: Asia-Pacific Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Asia-Pacific Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 226: Asia-Pacific 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• AUSTRALIA
  • Plantibodies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 227: Australia Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Australia Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 229: Australia 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
  • TABLE 230: Australia Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Australia Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 232: Australia 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
  • TABLE 233: Australia Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Australia Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 235: Australia 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 236: Australia Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Australia Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 238: Australia 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• INDIA
  • Plantibodies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 239: India Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 240: India Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 241: India 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
  • TABLE 242: India Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 243: India Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 244: India 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
  • TABLE 245: India Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 246: India Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 247: India 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 248: India Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 249: India Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 250: India 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• SOUTH KOREA
  • TABLE 251: South Korea Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 252: South Korea Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 253: South Korea 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
  • TABLE 254: South Korea Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 255: South Korea Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 256: South Korea 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
  • TABLE 257: South Korea Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 258: South Korea Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 259: South Korea 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 260: South Korea Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 261: South Korea Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 262: South Korea 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 263: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Rest of Asia-Pacific Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 265: Rest of Asia-Pacific 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
  • TABLE 266: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Rest of Asia-Pacific Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 268: Rest of Asia-Pacific 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
  • TABLE 269: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Rest of Asia-Pacific Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 271: Rest of Asia-Pacific 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 272: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Rest of Asia-Pacific Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 274: Rest of Asia-Pacific 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• LATIN AMERICA
  • Plantibodies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 275: Latin America Recent Past, Current & Future Analysis for Plantibodies by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 276: Latin America Historic Review for Plantibodies by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 277: Latin America 16-Year Perspective for Plantibodies by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
  • TABLE 278: Latin America Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Latin America Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 280: Latin America 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
  • TABLE 281: Latin America Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Latin America Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 283: Latin America 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
  • TABLE 284: Latin America Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Latin America Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 286: Latin America 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 287: Latin America Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Latin America Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 289: Latin America 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• ARGENTINA
  • TABLE 290: Argentina Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Argentina Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 292: Argentina 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
  • TABLE 293: Argentina Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Argentina Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 295: Argentina 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
  • TABLE 296: Argentina Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Argentina Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 298: Argentina 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 299: Argentina Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Argentina Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 301: Argentina 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• BRAZIL
  • TABLE 302: Brazil Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Brazil Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 304: Brazil 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
  • TABLE 305: Brazil Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Brazil Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 307: Brazil 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
  • TABLE 308: Brazil Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Brazil Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 310: Brazil 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 311: Brazil Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Brazil Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 313: Brazil 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• MEXICO
  • TABLE 314: Mexico Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Mexico Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 316: Mexico 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
  • TABLE 317: Mexico Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Mexico Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 319: Mexico 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
  • TABLE 320: Mexico Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 321: Mexico Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 322: Mexico 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 323: Mexico Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 324: Mexico Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 325: Mexico 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 326: Rest of Latin America Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 327: Rest of Latin America Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 328: Rest of Latin America 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
  • TABLE 329: Rest of Latin America Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 330: Rest of Latin America Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 331: Rest of Latin America 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
  • TABLE 332: Rest of Latin America Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 333: Rest of Latin America Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 334: Rest of Latin America 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 335: Rest of Latin America Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 336: Rest of Latin America Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 337: Rest of Latin America 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• MIDDLE EAST
  • Plantibodies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 338: Middle East Recent Past, Current & Future Analysis for Plantibodies by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 339: Middle East Historic Review for Plantibodies by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 340: Middle East 16-Year Perspective for Plantibodies by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
  • TABLE 341: Middle East Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 342: Middle East Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 343: Middle East 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
  • TABLE 344: Middle East Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 345: Middle East Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 346: Middle East 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
  • TABLE 347: Middle East Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 348: Middle East Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 349: Middle East 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 350: Middle East Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 351: Middle East Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 352: Middle East 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• IRAN
  • TABLE 353: Iran Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 354: Iran Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 355: Iran 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
  • TABLE 356: Iran Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 357: Iran Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 358: Iran 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
  • TABLE 359: Iran Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 360: Iran Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 361: Iran 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 362: Iran Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 363: Iran Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 364: Iran 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• ISRAEL
  • TABLE 365: Israel Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 366: Israel Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 367: Israel 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
  • TABLE 368: Israel Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 369: Israel Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 370: Israel 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
  • TABLE 371: Israel Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 372: Israel Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 373: Israel 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 374: Israel Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 375: Israel Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 376: Israel 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• SAUDI ARABIA
  • TABLE 377: Saudi Arabia Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 378: Saudi Arabia Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 379: Saudi Arabia 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
  • TABLE 380: Saudi Arabia Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 381: Saudi Arabia Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 382: Saudi Arabia 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
  • TABLE 383: Saudi Arabia Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 384: Saudi Arabia Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 385: Saudi Arabia 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 386: Saudi Arabia Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 387: Saudi Arabia Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 388: Saudi Arabia 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 389: UAE Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 390: UAE Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 391: UAE 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
  • TABLE 392: UAE Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 393: UAE Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 394: UAE 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
  • TABLE 395: UAE Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 396: UAE Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 397: UAE 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 398: UAE Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 399: UAE Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 400: UAE 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 401: Rest of Middle East Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 402: Rest of Middle East Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 403: Rest of Middle East 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
  • TABLE 404: Rest of Middle East Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 405: Rest of Middle East Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 406: Rest of Middle East 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
  • TABLE 407: Rest of Middle East Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 408: Rest of Middle East Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 409: Rest of Middle East 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 410: Rest of Middle East Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 411: Rest of Middle East Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 412: Rest of Middle East 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• AFRICA
  • Plantibodies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 413: Africa Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 414: Africa Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 415: Africa 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
  • TABLE 416: Africa Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 417: Africa Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 418: Africa 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
  • TABLE 419: Africa Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 420: Africa Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 421: Africa 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 422: Africa Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 423: Africa Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 424: Africa 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030

IV. COMPETITION